Impact of Isocitrate Dehydrogenase (IDH) Status on the Performance Status and Quality of Life (QOL) of Glioblastoma Multiforme (GBM) Patients
Oct 1, 2017, 00:00 AM
10.1016/j.jval.2017.08.310
https://www.valueinhealthjournal.com/article/S1098-3015(17)30644-7/fulltext
Section Title :
Disease-Specific Studies
Section Order :
291
First Page :
A453
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(17)30644-7&doi=10.1016/j.jval.2017.08.310